Gene Therapy - Table of Contents alert Volume 25 Issue 5

If you are unable to see the message below, click here to view.

Advertisement NATURE FEATURE: Growing Pains for Gene Therapy Manufacturing  Is there enough virus to go around?  Learn about the 3 major platforms for scaling up AAV manufacturing.   TABLE OF CONTENTS Volume 25, Issue 5 In this issue Article Brief Communication Also new AOP   Article LncRNA FTX sponges miR-215 and inhibits phosphorylation of vimentin for promoting colorectal cancer progression Yi Yang, Jinpei Zhang, Xi Chen, Xin Xu, Gang Cao et al. Gene Therapy 2018 25 :321 - 330; June 20, 2018; 10.1038/s41434-018-0026-7   Abstract | Full Text Characterization of a replicating expanded tropism oncolytic reovirus carrying the adenovirus E4orf4 gene Vera Kemp, Iris J. C. Dautzenberg, Steve J. Cramer, Rob C. Hoeben & Diana J. M. van den Wollenberg Gene Therapy 2018 25 :331 - 344; July 16, 2018; 10.1038/s41434-018-0032-9   Abstract | Full Text The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins Michael C. Paul-Smith, Kamila M. Pytel, Jean-François Gelinas, Jenny McIntosh, Ian Pringle et al. Gene Therapy 2018 25 :345 - 358; July 18, 2018; 10.1038/s41434-018-0025-8   Abstract | Full Text Brief Communication Electroporation-mediated delivery of FER gene enhances innate immune response and improves survival in a murine model of pneumonia Vladislav Dolgachev, Sreehari Panicker, Sanjay Balijepalli, Lane Kelly McCandless, Yue Yin et al. Gene Therapy 2018 25 :359 - 375; June 15, 2018; 10.1038/s41434-018-0022-y   Abstract | Full Text Stable and reproducible transgene expression independent of proliferative or differentiated state using BAC TG-EMBED Pankaj Chaturvedi, Binhui Zhao, David L. Zimmerman & Andrew S. Belmont Gene Therapy 2018 25 :376 - 391; June 21, 2018; 10.1038/s41434-018-0021-z   Abstract | Full Text More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose–response and comparison to AAV PHP.B Robert D. Dayton, Mychal S. Grames & Ronald L. Klein Gene Therapy 2018 25 :392 - 400; July 16, 2018; 10.1038/s41434-018-0028-5   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.